The global hepatitis B diagnostic tests market is on the cusp of substantial expansion, driven by a combination of increasing disease incidence, heightened global awareness campaigns, and rapid ...
On November 14, 2024, PAVmed Inc. (NASDAQ: PAVM, PAVMZ) released its financial results for the fiscal quarter ending September 30, 2024, along with significant business updates. The company revealed a ...